Global Meningococcal Infections Treatment Market Growth (Status and Outlook) 2023-2029

March 2023 | 61 pages | ID: G2F8050C2AFEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

Meningococcal meningitis are a major cause of bacterial meningitis and septicemia, usually occurs during infancy, adolescence and young adulthood and is characterized by an infectious syndrome with meningismus. Aggressive early treatment of meningococcal disease can reduce mortality.

LPI (LP Information)' newest research report, the “Meningococcal Infections Treatment Industry Forecast” looks at past sales and reviews total world Meningococcal Infections Treatment sales in 2022, providing a comprehensive analysis by region and market sector of projected Meningococcal Infections Treatment sales for 2023 through 2029. With Meningococcal Infections Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Meningococcal Infections Treatment industry.

This Insight Report provides a comprehensive analysis of the global Meningococcal Infections Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Meningococcal Infections Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Meningococcal Infections Treatment market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Meningococcal Infections Treatment and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Meningococcal Infections Treatment.

The global Meningococcal Infections Treatment market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Meningococcal Infections Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Meningococcal Infections Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Meningococcal Infections Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Meningococcal Infections Treatment players cover Pfizer, Sanofi, GlaxoSmithKline and Novartis, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Meningococcal Infections Treatment market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type

• Antibiotics
• Glucocorticoids
• Protein C Concentrate

Segmentation by application

• Hospitals
• Clinics
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Pfizer
• Sanofi
• GlaxoSmithKline
• Novartis

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Meningococcal Infections Treatment Market Size 2018-2029
  2.1.2 Meningococcal Infections Treatment Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Meningococcal Infections Treatment Segment by Type
  2.2.1 Antibiotics
  2.2.2 Glucocorticoids
  2.2.3 Protein C Concentrate
2.3 Meningococcal Infections Treatment Market Size by Type
  2.3.1 Meningococcal Infections Treatment Market Size CAGR by Type (2018 VS 2022 VS 2029)
  2.3.2 Global Meningococcal Infections Treatment Market Size Market Share by Type (2018-2023)
2.4 Meningococcal Infections Treatment Segment by Application
  2.4.1 Hospitals
  2.4.2 Clinics
  2.4.3 Others
2.5 Meningococcal Infections Treatment Market Size by Application
  2.5.1 Meningococcal Infections Treatment Market Size CAGR by Application (2018 VS 2022 VS 2029)
  2.5.2 Global Meningococcal Infections Treatment Market Size Market Share by Application (2018-2023)

3 MENINGOCOCCAL INFECTIONS TREATMENT MARKET SIZE BY PLAYER

3.1 Meningococcal Infections Treatment Market Size Market Share by Players
  3.1.1 Global Meningococcal Infections Treatment Revenue by Players (2018-2023)
  3.1.2 Global Meningococcal Infections Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Meningococcal Infections Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 MENINGOCOCCAL INFECTIONS TREATMENT BY REGIONS

4.1 Meningococcal Infections Treatment Market Size by Regions (2018-2023)
4.2 Americas Meningococcal Infections Treatment Market Size Growth (2018-2023)
4.3 APAC Meningococcal Infections Treatment Market Size Growth (2018-2023)
4.4 Europe Meningococcal Infections Treatment Market Size Growth (2018-2023)
4.5 Middle East & Africa Meningococcal Infections Treatment Market Size Growth (2018-2023)

5 AMERICAS

5.1 Americas Meningococcal Infections Treatment Market Size by Country (2018-2023)
5.2 Americas Meningococcal Infections Treatment Market Size by Type (2018-2023)
5.3 Americas Meningococcal Infections Treatment Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Meningococcal Infections Treatment Market Size by Region (2018-2023)
6.2 APAC Meningococcal Infections Treatment Market Size by Type (2018-2023)
6.3 APAC Meningococcal Infections Treatment Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Meningococcal Infections Treatment by Country (2018-2023)
7.2 Europe Meningococcal Infections Treatment Market Size by Type (2018-2023)
7.3 Europe Meningococcal Infections Treatment Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Meningococcal Infections Treatment by Region (2018-2023)
8.2 Middle East & Africa Meningococcal Infections Treatment Market Size by Type (2018-2023)
8.3 Middle East & Africa Meningococcal Infections Treatment Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL MENINGOCOCCAL INFECTIONS TREATMENT MARKET FORECAST

10.1 Global Meningococcal Infections Treatment Forecast by Regions (2024-2029)
  10.1.1 Global Meningococcal Infections Treatment Forecast by Regions (2024-2029)
  10.1.2 Americas Meningococcal Infections Treatment Forecast
  10.1.3 APAC Meningococcal Infections Treatment Forecast
  10.1.4 Europe Meningococcal Infections Treatment Forecast
  10.1.5 Middle East & Africa Meningococcal Infections Treatment Forecast
10.2 Americas Meningococcal Infections Treatment Forecast by Country (2024-2029)
  10.2.1 United States Meningococcal Infections Treatment Market Forecast
  10.2.2 Canada Meningococcal Infections Treatment Market Forecast
  10.2.3 Mexico Meningococcal Infections Treatment Market Forecast
  10.2.4 Brazil Meningococcal Infections Treatment Market Forecast
10.3 APAC Meningococcal Infections Treatment Forecast by Region (2024-2029)
  10.3.1 China Meningococcal Infections Treatment Market Forecast
  10.3.2 Japan Meningococcal Infections Treatment Market Forecast
  10.3.3 Korea Meningococcal Infections Treatment Market Forecast
  10.3.4 Southeast Asia Meningococcal Infections Treatment Market Forecast
  10.3.5 India Meningococcal Infections Treatment Market Forecast
  10.3.6 Australia Meningococcal Infections Treatment Market Forecast
10.4 Europe Meningococcal Infections Treatment Forecast by Country (2024-2029)
  10.4.1 Germany Meningococcal Infections Treatment Market Forecast
  10.4.2 France Meningococcal Infections Treatment Market Forecast
  10.4.3 UK Meningococcal Infections Treatment Market Forecast
  10.4.4 Italy Meningococcal Infections Treatment Market Forecast
  10.4.5 Russia Meningococcal Infections Treatment Market Forecast
10.5 Middle East & Africa Meningococcal Infections Treatment Forecast by Region (2024-2029)
  10.5.1 Egypt Meningococcal Infections Treatment Market Forecast
  10.5.2 South Africa Meningococcal Infections Treatment Market Forecast
  10.5.3 Israel Meningococcal Infections Treatment Market Forecast
  10.5.4 Turkey Meningococcal Infections Treatment Market Forecast
  10.5.5 GCC Countries Meningococcal Infections Treatment Market Forecast
10.6 Global Meningococcal Infections Treatment Forecast by Type (2024-2029)
10.7 Global Meningococcal Infections Treatment Forecast by Application (2024-2029)

11 KEY PLAYERS ANALYSIS

11.1 Pfizer
  11.1.1 Pfizer Company Information
  11.1.2 Pfizer Meningococcal Infections Treatment Product Offered
  11.1.3 Pfizer Meningococcal Infections Treatment Revenue, Gross Margin and Market Share (2018-2023)
  11.1.4 Pfizer Main Business Overview
  11.1.5 Pfizer Latest Developments
11.2 Sanofi
  11.2.1 Sanofi Company Information
  11.2.2 Sanofi Meningococcal Infections Treatment Product Offered
  11.2.3 Sanofi Meningococcal Infections Treatment Revenue, Gross Margin and Market Share (2018-2023)
  11.2.4 Sanofi Main Business Overview
  11.2.5 Sanofi Latest Developments
11.3 GlaxoSmithKline
  11.3.1 GlaxoSmithKline Company Information
  11.3.2 GlaxoSmithKline Meningococcal Infections Treatment Product Offered
  11.3.3 GlaxoSmithKline Meningococcal Infections Treatment Revenue, Gross Margin and Market Share (2018-2023)
  11.3.4 GlaxoSmithKline Main Business Overview
  11.3.5 GlaxoSmithKline Latest Developments
11.4 Novartis
  11.4.1 Novartis Company Information
  11.4.2 Novartis Meningococcal Infections Treatment Product Offered
  11.4.3 Novartis Meningococcal Infections Treatment Revenue, Gross Margin and Market Share (2018-2023)
  11.4.4 Novartis Main Business Overview
  11.4.5 Novartis Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Meningococcal Infections Treatment Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Antibiotics
Table 3. Major Players of Glucocorticoids
Table 4. Major Players of Protein C Concentrate
Table 5. Meningococcal Infections Treatment Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global Meningococcal Infections Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global Meningococcal Infections Treatment Market Size Market Share by Type (2018-2023)
Table 8. Meningococcal Infections Treatment Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global Meningococcal Infections Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global Meningococcal Infections Treatment Market Size Market Share by Application (2018-2023)
Table 11. Global Meningococcal Infections Treatment Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global Meningococcal Infections Treatment Revenue Market Share by Player (2018-2023)
Table 13. Meningococcal Infections Treatment Key Players Head office and Products Offered
Table 14. Meningococcal Infections Treatment Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Meningococcal Infections Treatment Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global Meningococcal Infections Treatment Market Size Market Share by Regions (2018-2023)
Table 19. Global Meningococcal Infections Treatment Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global Meningococcal Infections Treatment Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas Meningococcal Infections Treatment Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas Meningococcal Infections Treatment Market Size Market Share by Country (2018-2023)
Table 23. Americas Meningococcal Infections Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas Meningococcal Infections Treatment Market Size Market Share by Type (2018-2023)
Table 25. Americas Meningococcal Infections Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas Meningococcal Infections Treatment Market Size Market Share by Application (2018-2023)
Table 27. APAC Meningococcal Infections Treatment Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC Meningococcal Infections Treatment Market Size Market Share by Region (2018-2023)
Table 29. APAC Meningococcal Infections Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC Meningococcal Infections Treatment Market Size Market Share by Type (2018-2023)
Table 31. APAC Meningococcal Infections Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC Meningococcal Infections Treatment Market Size Market Share by Application (2018-2023)
Table 33. Europe Meningococcal Infections Treatment Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe Meningococcal Infections Treatment Market Size Market Share by Country (2018-2023)
Table 35. Europe Meningococcal Infections Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe Meningococcal Infections Treatment Market Size Market Share by Type (2018-2023)
Table 37. Europe Meningococcal Infections Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe Meningococcal Infections Treatment Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa Meningococcal Infections Treatment Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa Meningococcal Infections Treatment Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa Meningococcal Infections Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Meningococcal Infections Treatment Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa Meningococcal Infections Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Meningococcal Infections Treatment Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of Meningococcal Infections Treatment
Table 46. Key Market Challenges & Risks of Meningococcal Infections Treatment
Table 47. Key Industry Trends of Meningococcal Infections Treatment
Table 48. Global Meningococcal Infections Treatment Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global Meningococcal Infections Treatment Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global Meningococcal Infections Treatment Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global Meningococcal Infections Treatment Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. Pfizer Details, Company Type, Meningococcal Infections Treatment Area Served and Its Competitors
Table 53. Pfizer Meningococcal Infections Treatment Product Offered
Table 54. Pfizer Meningococcal Infections Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. Pfizer Main Business
Table 56. Pfizer Latest Developments
Table 57. Sanofi Details, Company Type, Meningococcal Infections Treatment Area Served and Its Competitors
Table 58. Sanofi Meningococcal Infections Treatment Product Offered
Table 59. Sanofi Main Business
Table 60. Sanofi Meningococcal Infections Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. Sanofi Latest Developments
Table 62. GlaxoSmithKline Details, Company Type, Meningococcal Infections Treatment Area Served and Its Competitors
Table 63. GlaxoSmithKline Meningococcal Infections Treatment Product Offered
Table 64. GlaxoSmithKline Main Business
Table 65. GlaxoSmithKline Meningococcal Infections Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. GlaxoSmithKline Latest Developments
Table 67. Novartis Details, Company Type, Meningococcal Infections Treatment Area Served and Its Competitors
Table 68. Novartis Meningococcal Infections Treatment Product Offered
Table 69. Novartis Main Business
Table 70. Novartis Meningococcal Infections Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. Novartis Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Meningococcal Infections Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Meningococcal Infections Treatment Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Meningococcal Infections Treatment Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Meningococcal Infections Treatment Sales Market Share by Country/Region (2022)
Figure 8. Meningococcal Infections Treatment Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Meningococcal Infections Treatment Market Size Market Share by Type in 2022
Figure 10. Meningococcal Infections Treatment in Hospitals
Figure 11. Global Meningococcal Infections Treatment Market: Hospitals (2018-2023) & ($ Millions)
Figure 12. Meningococcal Infections Treatment in Clinics
Figure 13. Global Meningococcal Infections Treatment Market: Clinics (2018-2023) & ($ Millions)
Figure 14. Meningococcal Infections Treatment in Others
Figure 15. Global Meningococcal Infections Treatment Market: Others (2018-2023) & ($ Millions)
Figure 16. Global Meningococcal Infections Treatment Market Size Market Share by Application in 2022
Figure 17. Global Meningococcal Infections Treatment Revenue Market Share by Player in 2022
Figure 18. Global Meningococcal Infections Treatment Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Meningococcal Infections Treatment Market Size 2018-2023 ($ Millions)
Figure 20. APAC Meningococcal Infections Treatment Market Size 2018-2023 ($ Millions)
Figure 21. Europe Meningococcal Infections Treatment Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Meningococcal Infections Treatment Market Size 2018-2023 ($ Millions)
Figure 23. Americas Meningococcal Infections Treatment Value Market Share by Country in 2022
Figure 24. United States Meningococcal Infections Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Meningococcal Infections Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Meningococcal Infections Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Meningococcal Infections Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Meningococcal Infections Treatment Market Size Market Share by Region in 2022
Figure 29. APAC Meningococcal Infections Treatment Market Size Market Share by Type in 2022
Figure 30. APAC Meningococcal Infections Treatment Market Size Market Share by Application in 2022
Figure 31. China Meningococcal Infections Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Meningococcal Infections Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Meningococcal Infections Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Meningococcal Infections Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Meningococcal Infections Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Meningococcal Infections Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Meningococcal Infections Treatment Market Size Market Share by Country in 2022
Figure 38. Europe Meningococcal Infections Treatment Market Size Market Share by Type (2018-2023)
Figure 39. Europe Meningococcal Infections Treatment Market Size Market Share by Application (2018-2023)
Figure 40. Germany Meningococcal Infections Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Meningococcal Infections Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Meningococcal Infections Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Meningococcal Infections Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Meningococcal Infections Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Meningococcal Infections Treatment Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Meningococcal Infections Treatment Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Meningococcal Infections Treatment Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Meningococcal Infections Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Meningococcal Infections Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Meningococcal Infections Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Meningococcal Infections Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Meningococcal Infections Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Meningococcal Infections Treatment Market Size 2024-2029 ($ Millions)
Figure 54. APAC Meningococcal Infections Treatment Market Size 2024-2029 ($ Millions)
Figure 55. Europe Meningococcal Infections Treatment Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Meningococcal Infections Treatment Market Size 2024-2029 ($ Millions)
Figure 57. United States Meningococcal Infections Treatment Market Size 2024-2029 ($ Millions)
Figure 58. Canada Meningococcal Infections Treatment Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Meningococcal Infections Treatment Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Meningococcal Infections Treatment Market Size 2024-2029 ($ Millions)
Figure 61. China Meningococcal Infections Treatment Market Size 2024-2029 ($ Millions)
Figure 62. Japan Meningococcal Infections Treatment Market Size 2024-2029 ($ Millions)
Figure 63. Korea Meningococcal Infections Treatment Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Meningococcal Infections Treatment Market Size 2024-2029 ($ Millions)
Figure 65. India Meningococcal Infections Treatment Market Size 2024-2029 ($ Millions)
Figure 66. Australia Meningococcal Infections Treatment Market Size 2024-2029 ($ Millions)
Figure 67. Germany Meningococcal Infections Treatment Market Size 2024-2029 ($ Millions)
Figure 68. France Meningococcal Infections Treatment Market Size 2024-2029 ($ Millions)
Figure 69. UK Meningococcal Infections Treatment Market Size 2024-2029 ($ Millions)
Figure 70. Italy Meningococcal Infections Treatment Market Size 2024-2029 ($ Millions)
Figure 71. Russia Meningococcal Infections Treatment Market Size 2024-2029 ($ Millions)
Figure 72. Spain Meningococcal Infections Treatment Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Meningococcal Infections Treatment Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Meningococcal Infections Treatment Market Size 2024-2029 ($ Millions)
Figure 75. Israel Meningococcal Infections Treatment Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Meningococcal Infections Treatment Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Meningococcal Infections Treatment Market Size 2024-2029 ($ Millions)
Figure 78. Global Meningococcal Infections Treatment Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Meningococcal Infections Treatment Market Size Market Share Forecast by Application (2024-2029)